C4 Therapeutics (CCCC) has provided an update.
The Company has announced Mr. Cooper’s addition to its Board with a press release, emphasizing that while this information is publicly shared, it isn’t considered formally filed or subject to certain legal liabilities. The release also clarifies that the announcement doesn’t imply the information’s materiality for investment decisions.
Learn more about CCCC stock on TipRanks’ Stock Analysis page.
